Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Chemosphere ; 349: 140706, 2024 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-37992907

RESUMO

The antidepressant fluoxetine is frequently detected in aquatic ecosystems, yet the effects on aquatic communities and ecosystems are still largely unknown. Therefore the aim of this study is to assess the effects of the long-term application of fluoxetine on key components of aquatic ecosystems including macroinvertebrate-, zooplankton-, phytoplankton- and microbial communities and organic matter decomposition by using traditional and non-traditional assessment methods. For this, we exposed 18 outdoor mesocosms (water volume of 1530 L and 10 cm of sediment) to five different concentrations of fluoxetine (0.2, 2, 20 and 200 µg/L) for eight weeks, followed by an eight-week recovery period. We quantified population and community effects by morphological identification, environmental DNA metabarcoding, in vitro and in vivo bioassays and measured organic matter decomposition as a measure of ecosystem functioning. We found effects of fluoxetine on bacterial, algal, zooplankton and macroinvertebrate communities and decomposition rates, mainly for the highest (200 µg/L) treatment. Treatment-related decreases in abundances were found for damselfly larvae (NOEC of 0.2 µg/L) and Sphaeriidae bivalves (NOEC of 20 µg/L), whereas Asellus aquaticus increased in abundance (NOEC <0.2 µg/L). Fluoxetine decreased photosynthetic activity and primary production of the suspended algae community. eDNA assessment provided additional insights by revealing that the algae belonging to the class Cryptophyceae and certain cyanobacteria taxa were the most negatively responding taxa to fluoxetine. Our results, together with results of others, suggest that fluoxetine can alter community structure and ecosystem functioning and that some impacts of fluoxetine on certain taxa can already be observed at environmentally realistic concentrations.


Assuntos
Ecossistema , Poluentes Químicos da Água , Animais , Fluoxetina/toxicidade , Código de Barras de DNA Taxonômico , Água Doce/química , Zooplâncton , Fitoplâncton , Antidepressivos/farmacologia , Bioensaio , Poluentes Químicos da Água/análise
2.
ISME J ; 10(4): 1002-14, 2016 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-26430856

RESUMO

The colonization pattern of intestinal microbiota during childhood may impact health later in life, but children older than 1 year are poorly studied. We followed healthy children aged 1-4 years (n=28) for up to 12 months, during which a synbiotic intervention and occasional antibiotics intake occurred, and compared them with adults from the same region. Microbiota was quantified with the HITChip phylogenetic microarray and analyzed with linear mixed effects model and other statistical approaches. Synbiotic administration increased the stability of Actinobacteria and antibiotics decreased Clostridium cluster XIVa abundance. Bacterial diversity did not increase in 1- to 5-year-old children and remained significantly lower than in adults. Actinobacteria, Bacilli and Clostridium cluster IV retained child-like abundances, whereas some other groups were converting to adult-like profiles. Microbiota stability increased, with Bacteroidetes being the main contributor. The common core of microbiota in children increased with age from 18 to 25 highly abundant genus-level taxa, including several butyrate-producing organisms, and developed toward an adult-like composition. In conclusion, intestinal microbiota is not established before 5 years of age and diversity, core microbiota and different taxa are still developing toward adult-type configuration. Discordant development patterns of bacterial phyla may reflect physiological development steps in children.


Assuntos
Actinobacteria , Bacillus , Clostridium , Fezes/microbiologia , Microbioma Gastrointestinal , Adulto , Fatores Etários , Biodiversidade , Pré-Escolar , Feminino , Seguimentos , Humanos , Lactente , Modelos Lineares , Estudos Longitudinais , Masculino , Pessoa de Meia-Idade , Filogenia , Probióticos/química , Adulto Jovem
3.
ISME J ; 8(8): 1621-33, 2014 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-24577353

RESUMO

Recurrent Clostridium difficile infection (CDI) can be effectively treated by infusion of a healthy donor faeces suspension. However, it is unclear what factors determine treatment efficacy. By using a phylogenetic microarray platform, we assessed composition, diversity and dynamics of faecal microbiota before, after and during follow-up of the transplantation from a healthy donor to different patients, to elucidate the mechanism of action of faecal infusion. Global composition and network analysis of the microbiota was performed in faecal samples from nine patients with recurrent CDI. Analyses were performed before and after duodenal donor faeces infusion, and during a follow-up of 10 weeks. The microbiota data were compared with that of the healthy donors. All patients successfully recovered. Their intestinal microbiota changed from a low-diversity diseased state, dominated by Proteobacteria and Bacilli, to a more diverse ecosystem resembling that of healthy donors, dominated by Bacteroidetes and Clostridium groups, including butyrate-producing bacteria. We identified specific multi-species networks and signature microbial groups that were either depleted or restored as a result of the treatment. The changes persisted over time. Comprehensive and deep analyses of the microbiota of patients before and after treatment exposed a therapeutic reset from a diseased state towards a healthy profile. The identification of microbial groups that constitute a niche for C. difficile overgrowth, as well as those driving the reinstallation of a healthy intestinal microbiota, could contribute to the development of biomarkers predicting recurrence and treatment outcome, identifying an optimal microbiota composition that could lead to targeted treatment strategies.


Assuntos
Clostridioides difficile , Infecções por Clostridium/microbiologia , Fezes/microbiologia , Microbiota , Infecções por Clostridium/terapia , Humanos , Intestinos/microbiologia , Filogenia , Recidiva
4.
Environ Microbiol ; 11(12): 3223-32, 2009 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-19703218

RESUMO

Anaerobic oxidation of methane (AOM) is an important methane sink in the ocean but the microbes responsible for AOM are as yet resilient to cultivation. Here we describe the microbial analysis of an enrichment obtained in a novel submerged-membrane bioreactor system and capable of high-rate AOM (286 mumol g(dry weight)(-1) day(-1)) coupled to sulfate reduction. By constructing a clone library with subsequent sequencing and fluorescent in situ hybridization, we showed that the responsible methanotrophs belong to the ANME-2a subgroup of anaerobic methanotrophic archaea, and that sulfate reduction is most likely performed by sulfate-reducing bacteria commonly found in association with other ANME-related archaea in marine sediments. Another relevant portion of the bacterial sequences can be clustered within the order of Flavobacteriales but their role remains to be elucidated. Fluorescent in situ hybridization analyses showed that the ANME-2a cells occur as single cells without close contact to the bacterial syntrophic partner. Incubation with (13)C-labelled methane showed substantial incorporation of (13)C label in the bacterial C(16) fatty acids (bacterial; 20%, 44% and 49%) and in archaeal lipids, archaeol and hydroxyl-archaeol (21% and 20% respectively). The obtained data confirm that both archaea and bacteria are responsible for the anaerobic methane oxidation in a bioreactor enrichment inoculated with Eckernförde bay sediment.


Assuntos
Archaea/classificação , Metano/metabolismo , Sulfatos/metabolismo , Bactérias Redutoras de Enxofre/classificação , Anaerobiose , Archaea/genética , Archaea/metabolismo , Biodiversidade , Reatores Biológicos/microbiologia , Sedimentos Geológicos/microbiologia , Filogenia , RNA Ribossômico 16S/metabolismo , Água do Mar/microbiologia , Bactérias Redutoras de Enxofre/genética , Bactérias Redutoras de Enxofre/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA